Home Study Details

    Program Type

    Home Study Webcast


    1.25 Contact Hour(s)

    Release Date

    Monday, April 20, 2020

    Offline Date

    Thursday, April 20, 2023

    ACPE Expiration Date

    Thursday, April 20, 2023

    Target Audience




    • Overview

      Should gabapentin be a controlled substance? Well, relative to any other substance affecting the general GABA receptors and channels, a healthcare professional should not be surprised at the recent reclassification of gabapentin (or other gabapentinoids) to being a controlled substance in areas of the country. After all, benzodiazepines (benzos), ethyl alcohol, and some seizure medications (in other words a decent group of sedatives) function in the very same general mechanism, so why in the world wouldn’t these substances be controlled substances? Then again, just because a substance is a controlled substance, doesn’t necessarily mean that they should be avoided outright within patient care either. (For substances such as “roofies” or the “date-rape drug," perhaps the balance between appropriate utilization and major safety concerns is a little more one-sided.) This discussion is also part of the overall Substances of Abuse Specialty Pharmacist (SASP) certificate training program. So please join us for a thorough review of all sedatives provoking their action within the general GABA-related mechanisms of action. Unlike these sedatives, this discussion is sure to peak one’s arousal and alertness to key patient care points.


      • Slide Document :   20065H04_2pp.pdf
      • Slide Document :   20065H04_6pp.pdf

      Financial Support By

    • Pharmacist

      Distinguish between gabapentinoid overuse and withdrawal symptoms.
      Identify typical administration and utilization trends of common GABA-related sedative substances of abuse whether of illegal, prescription, over-the-counter, or supplement origin.
      Distinguish benzodiazepine substances based legal status, approved uses, duration of action, and structural class.
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-20-065-H04-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).